1887
Japanese
/ English
About PierOnline
User Guide
Q&A
Shopping cart
this publication
all PierOnline
Advanced Search
Journals
Books
Series
Subjects
For Publishers
About PierOnline
BROWSE BY:
Publication
Publisher
Sign in
Sign in
Username
Password
Can't access your account?
Sign in
via
Shibboleth
Subscribers sign-in for full text access
Register
Tools
Subscribe to email alerts
Subscribe to RSS
Key
Free Content
Subscribed Content
Home
>
Publishers
>
癌と化学療法社
>
癌と化学療法
>
34巻Supplement I
癌と化学療法
Overview
Browse
2007, 34巻Supplement I
Show
/
Hide
descriptions
Volumes & issues:
Volume 51 (2024)
Volume 50 (2023)
Volume 49 (2022)
Volume 48 (2021)
Volume 47 (2020)
Volume 46 (2019)
Volume 45 (2018)
Volume 44 (2017)
Volume 43 (2016)
Volume 42 (2015)
Volume 41 (2014)
Volume 40 (2013)
Volume 39 (2012)
Volume 38 (2011)
Volume 37 (2010)
Volume 36 (2009)
Volume 35 (2008)
Volume 34 (2007)
Volume 33 (2006)
Volume 32 (2005)
Volume 31 (2004)
I. 新しい戦略による抗がん剤のスクリーニングのための委員会報告—制がん候補物質のスクリーニング成績・第11報—
I. 抗がん剤スクリーニングの新戦略
Author:
※休止中
From PierOnline
From PubMed
From Google Scholar
Source:
癌と化学療法
34巻Supplement I
,
1-1
(2007)
;
View Description
Hide Description
Add to my favorites
Export citations
BibT
E
X
EndNote
Plain text
RefWorks
Email this
III-2-9. マウス白血病 P 388による抗がん効果の検定
Author:
※休止中
From PierOnline
From PubMed
From Google Scholar
Source:
癌と化学療法
34巻Supplement I
,
8-8
(2007)
;
View Description
Hide Description
Add to my favorites
Export citations
BibT
E
X
EndNote
Plain text
RefWorks
Email this
III-3. 旧スクリーニング委員会—1次スクリーニングの実施状況および結果のまとめ
Author:
※休止中
From PierOnline
From PubMed
From Google Scholar
Source:
癌と化学療法
34巻Supplement I
,
9-9
(2007)
;
View Description
Hide Description
Add to my favorites
Export citations
BibT
E
X
EndNote
Plain text
RefWorks
Email this
凡例
Author:
※休止中
From PierOnline
From PubMed
From Google Scholar
Source:
癌と化学療法
34巻Supplement I
,
10-10
(2007)
;
View Description
Hide Description
Add to my favorites
Export citations
BibT
E
X
EndNote
Plain text
RefWorks
Email this
化合物
Author:
※休止中
From PierOnline
From PubMed
From Google Scholar
Source:
癌と化学療法
34巻Supplement I
,
11-11
(2007)
;
View Description
Hide Description
Add to my favorites
Export citations
BibT
E
X
EndNote
Plain text
RefWorks
Email this
II. 化学療法基盤情報支援班報告—制がん候補物質のスクリーニング成績・第12報—
化学療法基盤情報支援班について
Author:
※休止中
From PierOnline
From PubMed
From Google Scholar
Source:
癌と化学療法
34巻Supplement I
,
112-112
(2007)
;
View Description
Hide Description
Add to my favorites
Export citations
BibT
E
X
EndNote
Plain text
RefWorks
Email this
I-3)ヒストンデアセチラーゼ阻害活性の検定
Author:
※休止中
From PierOnline
From PubMed
From Google Scholar
Source:
癌と化学療法
34巻Supplement I
,
115-115
(2007)
;
View Description
Hide Description
Add to my favorites
Export citations
BibT
E
X
EndNote
Plain text
RefWorks
Email this
II. 標準阻害剤キットの整備とその提供
Author:
※休止中
From PierOnline
From PubMed
From Google Scholar
Source:
癌と化学療法
34巻Supplement I
,
118-118
(2007)
;
View Description
Hide Description
Add to my favorites
Export citations
BibT
E
X
EndNote
Plain text
RefWorks
Email this
化合物
Author:
※休止中
From PierOnline
From PubMed
From Google Scholar
Source:
癌と化学療法
34巻Supplement I
,
123-123
(2007)
;
View Description
Hide Description
Add to my favorites
Export citations
BibT
E
X
EndNote
Plain text
RefWorks
Email this
一部のサンプルの化学構造式拡大図
Author:
※休止中
From PierOnline
From PubMed
From Google Scholar
Source:
癌と化学療法
34巻Supplement I
,
143-143
(2007)
;
View Description
Hide Description
Add to my favorites
Export citations
BibT
E
X
EndNote
Plain text
RefWorks
Email this
おわりに
Author:
※休止中
From PierOnline
From PubMed
From Google Scholar
Source:
癌と化学療法
34巻Supplement I
,
145-145
(2007)
;
View Description
Hide Description
Add to my favorites
Export citations
BibT
E
X
EndNote
Plain text
RefWorks
Email this
索引
Author:
※休止中
From PierOnline
From PubMed
From Google Scholar
Source:
癌と化学療法
34巻Supplement I
,
146-146
(2007)
;
View Description
Hide Description
Add to my favorites
Export citations
BibT
E
X
EndNote
Plain text
RefWorks
Email this
This is a required field
Please enter a valid email address
Oops! This section,
does not exist...
Use the links on this page to find existing content.
Sign in or Register
Please sign in or register to use this feature
Complete your profile
Please complete your profile to use this feature